Therapeutic efficacy and safety of Kangfuxin in combination with rabeprazole in the treatment of peptic ulcer: A systematic review and meta-analysis

BACKGROUND: Kangfuxin (KFX), a well-known Chinese patent medicine which extracted from Periplaneta americana, is widely used as an adjuvant in the treatment of peptic ulcers (PUs) with proton pump inhibitors (PPIs) such as rabeprazole, in China. However, no clear consensus has been reached on the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Meisi, Zhang, Siyuan, Zhang, Minyue, Shi, Jinfeng, Zhang, Chen, Luo, Ruifeng, You, Jieshu, Sun, Jiayi, Zhang, Jinming, Gao, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710217/
https://www.ncbi.nlm.nih.gov/pubmed/33235070
http://dx.doi.org/10.1097/MD.0000000000023103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710217/
https://www.ncbi.nlm.nih.gov/pubmed/33235070
http://dx.doi.org/10.1097/MD.0000000000023103

Ejemplares similares